Show simple item record

Safety and immunogenicity of the VRC recombinant multiclade HIV-1 adenoviral vector vaccine alone or in combination with the VRC multiclade HIV-1 DNA plasmid vaccine in healthy African adults (2009).

dc.contributor.authorOmosa-Manyonyi, G
dc.contributor.authorJaoko, W
dc.contributor.authorAnzala, O
dc.contributor.authorOgutu, H
dc.contributor.authorNdambuki, R
dc.contributor.authorWakasiaka, S
dc.contributor.authorMalogo, R
dc.contributor.authorKayitenkore, K
dc.contributor.authorKarita, E
dc.contributor.authorSchmidt, C
dc.contributor.authorFast, P
dc.contributor.authorKomaroff, W
dc.contributor.authorCooper, A
dc.contributor.authorBoaz, M
dc.contributor.authorGilmour, J
dc.contributor.authorDally, L
dc.contributor.authorHo, M
dc.contributor.authorSmith, C
dc.contributor.authorGraham, B
dc.date.accessioned2013-12-02T12:21:40Z
dc.date.available2013-12-02T12:21:40Z
dc.date.issued2009
dc.identifier.citationOmosa-Manyonyi G, Jaoko W, Anzala O, Ogutu H, Ndambuki R, Wakasiaka S, Malogo R, Kayitenkore K, Karita E, Schmidt C, Fast P, Komaroff W, Cooper A, Boaz M, Gilmour J, Dally L, Ho M, Smith C, Graham B. Safety and immunogenicity of the VRC recombinant multiclade HIV-1 adenoviral vector vaccine alone or in combination with the VRC multiclade HIV-1 DNA plasmid vaccine in healthy African adults (2009). Oral presentation at The Kenya Medical Association 36th Annual Scientific Conference (2008)en
dc.identifier.urihttp://hdl.handle.net/11295/61432
dc.language.isoenen
dc.publisherUniversity of Nairobien
dc.titleSafety and immunogenicity of the VRC recombinant multiclade HIV-1 adenoviral vector vaccine alone or in combination with the VRC multiclade HIV-1 DNA plasmid vaccine in healthy African adults (2009).en
dc.typePresentationen
local.publisherSchool of Medicineen


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record